PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +11 vs. previous quarter
- 52
- 13F valueReported value at the end of Q2 2026
- $6.78M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PDSB, Q2 2026
No superinvestor reported holding PDSB at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by PDS Biotechnology Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 (view filing) | Feb 28 | 3 days | Freitag Gregory GeneDirector | PPurchase | +15.1K | $1.66 | +$25.0K | +32.6%61.2K after | |
| Mar 3, 2025 (view filing) | Feb 28 | 3 days | Freitag Gregory GeneDirector | PPurchase | +15.1K | – | – | –15.1K after | Derivative |
| Mar 3, 2025 (view filing) | Feb 28 | 3 days | Glover Steve CDirector | PPurchase | +15.1K | $1.66 | +$25.0K | +23.6%78.9K after | |
| Mar 3, 2025 (view filing) | Feb 28 | 3 days | Glover Steve CDirector | PPurchase | +15.1K | – | – | –15.1K after | Derivative |
| Dec 14, 2021 (view filing) | Dec 13 | 1 day | Hill Matthew CChief Financial Officer | PPurchase | +2.90K | $8.99 | +$26.1K | +297.4%3.88K after | 2 lots |
| Dec 14, 2021 (view filing) | Dec 13 | 1 day | Hill Matthew CChief Financial Officer | PPurchase | +200 | $9.00 | +$1.80K | +5.2%4.08K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in PDS Biotechnology Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1,699,315 | $1.50M | 0.00% | +68,226+4.2% | Added |
| Colony Group, LLC | 642,177 | $565.8K | 0.00% | +642,177 | New |
| Quantinno Capital Management LP | 642,177 | $565.8K | 0.00% | +642,177 | New |
| BlackRock, Inc. | 607,639 | $535.4K | 0.00% | +53,591+9.7% | Added |
| Geode Capital Management, LLC | 587,139 | $517.4K | 0.00% | −73,089−11.1% | Reduced |
| Vanguard Fiduciary Trust Co | 357,144 | $314.6K | 0.00% | +49,833+16.2% | Added |
| Militia Capital Management LLC | 331,800 | $292.3K | 0.05% | +331,800 | New |
| Citadel Advisors LLC | 323,801 | $285.3K | 0.00% | +323,801 | New |
| Morgan Stanley | 313,922 | $276.6K | 0.00% | +310,000+7,904.1% | Added |
| Blair William & Co | 300,000 | $264.3K | 0.00% | 00.0% | Unchanged |